President and CEO Helen Torley sold $2.1M of Halozyme Therapeutics, Inc.

Sold$2,118,846

$42.38Price

50,000Shares

−9%Stake

What HALO did after the filing

Prices for HALO after this filing aren't in yet.

Traded Tue, Sep 7. Filed Tue, Sep 7, 5:46 PM ET, after the close. Not investment advice.